Barclays Sticks to Their Hold Rating for Procter & Gamble (PG)
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG) with a $152.00 price target. TD Cowen also kept a Hold rating with a $150.00 target. PG reported Q2 revenue of $21.2B and net profit of $3B, down from $3.62B last year. Insider sentiment is negative, with recent sales by executives.
How this was made

The 30-second read
Why it matters
The reaffirmation of Hold and modest insider sell provide limited new information for traders.
Market read
Routine rating reaffirmation and small insider sale; minimal impact on PG price.
What to watch
Potential upcoming product launches or cost initiatives not covered in this brief.
Background
Barclays analyst Lauren Lieberman covers Consumer Defensive stocks and reaffirmed a Hold stance on PG with a $152 price target. TD Cowen also held its rating.
Ticker impact
Barclays maintained a Hold rating on Procter & Gamble and reported an insider sale of 3,053 shares worth $438,990.87.
Minor downward pressure, likely within normal volatility range.
No change in rating or target, and insider sale size is small relative to market cap; limited trading impact.
Market effects
None significant for Consumer Staples sector.
Limited to US market where PG trades.
Low; PG is a large cap but news is routine.
Counterpoint
The hold rating may be undervalued if earnings beat expectations later.
Key entities
- Analyst FirmBarclays
Maintained Hold rating on PG.
- AnalystLauren Lieberman
Barclays analyst covering PG.
- InsiderMoses Victor Javier Aguilar
PG Chief Research, Development & Innovation Officer who sold shares.




